All In MedTech

Device Trial Radar · NCT03570034

Obalon Balloon System Post-Approval Study

Obalon Balloon System - Post-Approval Study

Last checked: Nov 20, 2026Latest source record: Apr 30, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

201

Actual

Start

Jun 15, 2018

Primary completion

Sep 13, 2020

Study completion Mar 13, 2021

Sponsor

Lead sponsor
Obalon Therapeutics, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jun 26, 2018

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The Obalon Balloon System - Post-Approval Study is a prospective, observational, and multi-center study.

Conditions

  • Obesity

Interventions

  • Obalon Balloon SystemDevice

    Obalon Balloon System with a moderate intensity Weight Loss Behavioral Modification Program

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Serious Adverse EventTime frame: 6-Month
  2. Percentage of Patients with at least 5% TBWLTime frame: 6-Month
  3. Mean % TBWLTime frame: 6-Month

Locations

15 sites in 1 country. Site status is shown where the registry gives one.

  • Smart Dimensions Weight Loss

    Fountain Valley, California

  • Davtyan Medical Weight Loss and Wellness

    Glendale, California

  • Lifetime Surgical Weight Loss

    Los Gatos, California

12 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.